Since its launch in June, the interactive educational biosimilars resource tool on the Vanguard website has had: - Over 17,000 page views - Almost 11,000 of these are unique page views - Over 4,000 users from as far afield as India and Australia
This website is one of the products of the collaboration between Sandoz Ltd and the Cancer Vanguard.
The Cancer Vanguard’s Pharma Challenge was a revolutionary way for the health service and the pharmaceutical industry to work in partnership to improve cancer drugs provision, and so benefit patients.
The biosimilars programme was developed to help improve healthcare professionals’ understanding of biosimilar medicines and help them to better inform patients about their use and assist in their timely introduction.
NHS England Specialised Commissioning has advised wider implementation of biosimilars and recommends that Trusts use the Vanguard resource for advice and support.
You can find out more about biosimilar medicines at: https://cancervanguard.nhs.uk/biosimilars-adoption/